NAD+ improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1/PGC-1α pathway.
J Neuroinflammation
; 18(1): 207, 2021 Sep 16.
Article
in En
| MEDLINE
| ID: mdl-34530866
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Reactive Oxygen Species
/
Sirtuin 1
/
Cognitive Dysfunction
/
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
/
Neuroinflammatory Diseases
/
Mitochondria
/
NAD
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
J Neuroinflammation
Journal subject:
NEUROLOGIA
Year:
2021
Type:
Article
Affiliation country:
China